{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:49:25Z","timestamp":1780069765165,"version":"3.54.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurosurgery Clinics of North America"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.nec.2019.05.009","type":"journal-article","created":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T01:03:47Z","timestamp":1562979827000},"page":"491-498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Endocrine Outcomes After Pituitary Surgery"],"prefix":"10.1016","volume":"30","author":[{"given":"Anshu","family":"Buttan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam N.","family":"Mamelak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.nec.2019.05.009_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1227\/01.NEU.0000325725.77132.90","article-title":"Pituitary hormonal loss and recovery after transsphenoidal adenoma removal","volume":"63","author":"Fatemi","year":"2008","journal-title":"Neurosurgery"},{"issue":"10","key":"10.1016\/j.nec.2019.05.009_bib2","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1210\/jcem.84.10.6019","article-title":"Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas","volume":"84","author":"Webb","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.nec.2019.05.009_bib3","first-page":"589","article-title":"Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis","volume":"124","author":"Jahangiri","year":"2016","journal-title":"J\u00a0Neurosurg"},{"issue":"5","key":"10.1016\/j.nec.2019.05.009_bib4","first-page":"1577","article-title":"Relative\u00a0sparing of anterior pituitary function in patients with growth hormone-secreting macroadenomas: comparison with nonfunctioning macroadenomas","volume":"80","author":"Greenman","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.nec.2019.05.009_bib5","doi-asserted-by":"crossref","first-page":"832","DOI":"10.4158\/EP14541.DSCR","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology disease state clinical review: postoperative management following pituitary surgery","volume":"21","author":"Woodmansee","year":"2015","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.nec.2019.05.009_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11102-010-0227-6","article-title":"Immediate postoperative cortisol levels accurately predict postoperative hypothalamic-pituitary-adrenal axis function after transsphenoidal surgery for pituitary tumors","volume":"13","author":"Marko","year":"2010","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.nec.2019.05.009_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2265.2007.02995.x","article-title":"Prospective evaluation of a protocol for reduced glucocorticoid replacement in transsphenoidal pituitary adenomectomy: prophylactic glucocorticoid replacement is seldom necessary","volume":"68","author":"Wentworth","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.nec.2019.05.009_bib8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/02688690310001611233","article-title":"Hydrocortisone dose and postoperative diabetes insipidus in patients undergoing transsphenoidal pituitary surgery: a prospective randomized controlled study","volume":"17","author":"Rajaratnam","year":"2003","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.nec.2019.05.009_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fendo.2013.00030","article-title":"Selective use of peri-operative steroids in pituitary tumor surgery: escape from dogma","volume":"4","author":"Regan","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.nec.2019.05.009_bib10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1507\/endocrj.52.751","article-title":"High risk of osteopenia and bone derangement in postsurgical patients with craniopharyngiomas, pituitary adenomas and other parasellar lesions","volume":"52","author":"Okinaga","year":"2005","journal-title":"Endocr J"},{"issue":"10","key":"10.1016\/j.nec.2019.05.009_bib11","doi-asserted-by":"crossref","first-page":"E1938","DOI":"10.1210\/jc.2012-2432","article-title":"Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma","volume":"97","author":"Zueger","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.nec.2019.05.009_bib12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000430815","article-title":"Hypothalamic-pituitary axis in non-functioning pituitary adenomas: focus on the prevalence of isolated central hypoadrenalism","volume":"102","author":"Carosi","year":"2015","journal-title":"Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.nec.2019.05.009_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2265.2005.02231.x","article-title":"Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up","volume":"62","author":"Karavitaki","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.nec.2019.05.009_bib14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/cen.13048","article-title":"Recovery of adrenal function after chronic secondary adrenal insufficiency in patients with hypopituitarism","volume":"85","author":"Munro","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"10.1016\/j.nec.2019.05.009_bib15","doi-asserted-by":"crossref","first-page":"E1163","DOI":"10.1210\/jc.2010-2673","article-title":"Low incidence of adrenal insufficiency after transsphenoidal surgery in patients with acromegaly: a long-term follow-up study","volume":"96","author":"Burgers","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.nec.2019.05.009_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/07853890.2010.530680","article-title":"Endocrine disorders: causes of hyponatremia not to neglect","volume":"43","author":"Liamis","year":"2011","journal-title":"Ann Med"},{"issue":"4","key":"10.1016\/j.nec.2019.05.009_bib17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00000658-199404000-00013","article-title":"Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem","volume":"219","author":"Salem","year":"1994","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.nec.2019.05.009_bib18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.wneu.2012.07.034","article-title":"Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts","volume":"80","author":"McLaughlin","year":"2013","journal-title":"World Neurosurg"},{"issue":"1","key":"10.1016\/j.nec.2019.05.009_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2265.1997.d01-1748.x","article-title":"Which patients benefit from provocative adrenal testing after transsphenoidal pituitary surgery?","volume":"46","author":"Auchus","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.nec.2019.05.009_bib20","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jcem.87.6.8547","article-title":"Glucocorticoid replacement in pituitary surgery: guidelines for perioperative assessment and management","volume":"87","author":"Inder","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.nec.2019.05.009_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/0885066605275247","article-title":"Postoperative care following pituitary surgery","volume":"20","author":"Dumont","year":"2005","journal-title":"J\u00a0Intensive Care Med"},{"issue":"4","key":"10.1016\/j.nec.2019.05.009_bib22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1530\/EJE-12-0921","article-title":"Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study","volume":"168","author":"Alexandraki","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.nec.2019.05.009_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00701-007-1133-1","article-title":"Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease","volume":"149","author":"Acebes","year":"2007","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"10.1016\/j.nec.2019.05.009_bib24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2265.2008.03334.x","article-title":"Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD)","volume":"70","author":"Wagenmakers","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.nec.2019.05.009_bib25","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"10.1016\/j.nec.2019.05.009_bib26","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.4103\/2230-8210.83337","article-title":"Central hypothyroidism","volume":"15","author":"Gupta","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.nec.2019.05.009_bib27","first-page":"3631","article-title":"Circulating thyrotropin bioactivity in sporadic central hypothyroidism","volume":"85","author":"Persani","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.nec.2019.05.009_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF03345476","article-title":"Prevalence and severity of hyponatremia and hypercreatininemia in short-term uncomplicated hypothyroidism","volume":"22","author":"Baajafer","year":"1999","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.nec.2019.05.009_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1472-6823-13-27","article-title":"Acute severe hypothyroidism is not associated with hyponatremia even with increased water intake: a prospective study in thyroid cancer patients","volume":"13","author":"Hammami","year":"2013","journal-title":"BMC Endocr Disord"},{"issue":"6","key":"10.1016\/j.nec.2019.05.009_bib30","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.beem.2009.08.003","article-title":"Drugs that suppress TSH or cause central hypothyroidism","volume":"23","author":"Haugen","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.nec.2019.05.009_bib31","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1172\/JCI106176","article-title":"The effect of glucocorticoids on thyrotropin secretion","volume":"48","author":"Wilber","year":"1969","journal-title":"J\u00a0Clin Invest"},{"issue":"9","key":"10.1016\/j.nec.2019.05.009_bib32","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1089\/105072502760339406","article-title":"Thyrotropin suppression by thyroid hormone replacement is\u00a0correlated with thyroxine level normalization in\u00a0central hypothyroidism","volume":"12","author":"Shimon","year":"2002","journal-title":"Thyroid"},{"issue":"11","key":"10.1016\/j.nec.2019.05.009_bib33","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1210\/jc.2007-0297","article-title":"Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine","volume":"92","author":"Slawik","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.nec.2019.05.009_bib34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4158\/EP.14.5.550","article-title":"Optimal free thyroxine levels for thyroid hormone replacement in hypothyroidism","volume":"14","author":"Iverson","year":"2008","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.nec.2019.05.009_bib35","first-page":"924","article-title":"Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism","volume":"84","author":"Ferretti","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.nec.2019.05.009_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11102-008-0122-6","article-title":"Central hypothyroidism","volume":"11","author":"Lania","year":"2008","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.nec.2019.05.009_bib37","first-page":"521","article-title":"Thyrotropin-producing pituitary adenomas","volume":"79","author":"Mindermann","year":"1993","journal-title":"J\u00a0Neurosurg"},{"issue":"6","key":"10.1016\/j.nec.2019.05.009_bib38","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1210\/jc.2013-4376","article-title":"Thyrotropin-secreting pituitary adenomas: outcome of pituitary surgery and irradiation","volume":"99","author":"Malchiodi","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.nec.2019.05.009_bib39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1530\/eje.0.1480433","article-title":"The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients","volume":"148","author":"Socin","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.nec.2019.05.009_bib40","first-page":"540","article-title":"Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in\u00a0vivo and in\u00a0vitro hormonal secretions","volume":"75","author":"Bertherat","year":"1992","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.nec.2019.05.009_bib41","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1210\/jc.2012-3550","article-title":"Approach to the patient with hypogonadotropic hypogonadism","volume":"98","author":"Silveira","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9122","key":"10.1016\/j.nec.2019.05.009_bib42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(98)85043-5","article-title":"Pituitary insufficiency","volume":"352","author":"Lamberts","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.nec.2019.05.009_bib43","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.maturitas.2013.02.001","article-title":"Global Consensus Statement on menopausal hormone therapy","volume":"74","author":"de Villiers","year":"2013","journal-title":"Maturitas"},{"issue":"14","key":"10.1016\/j.nec.2019.05.009_bib44","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.nec.2019.05.009_bib45","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1210\/jc.2012-2403","article-title":"A\u00a0decade after the women's health initiative\u2013the experts do agree","volume":"97","author":"Stuenkel","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.nec.2019.05.009_bib46","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1210\/jc.2018-00404","article-title":"The efficacy and adverse events of testosterone replacement therapy in hypogonadal men: a systematic review and meta-analysis of randomized, placebo-controlled trials","volume":"103","author":"Ponce","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl 6","key":"10.1016\/j.nec.2019.05.009_bib47","first-page":"S9","article-title":"Testosterone replacement in men with andropause: an overview","volume":"6","author":"Brawer","year":"2004","journal-title":"Rev Urol"},{"issue":"5","key":"10.1016\/j.nec.2019.05.009_bib48","doi-asserted-by":"crossref","first-page":"847","DOI":"10.4158\/EP13217.RA","article-title":"Andropause or male menopause? Rationale for testosterone replacement therapy in older men with low testosterone levels","volume":"19","author":"Cunningham","year":"2013","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.nec.2019.05.009_bib49","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/jama.2015.8881","article-title":"Effects of testosterone administration for 3 years on subclinical atherosclerosis progression in older men with low or low-normal testosterone levels: a randomized clinical trial","volume":"314","author":"Basaria","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.nec.2019.05.009_bib50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/jcem.87.2.8216","article-title":"Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?","volume":"87","author":"Hartman","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.nec.2019.05.009_bib51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1530\/EJE-09-0222","article-title":"Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments","volume":"161","author":"Ronchi","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"8920","key":"10.1016\/j.nec.2019.05.009_bib52","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(94)91821-X","article-title":"Diagnosis of growth hormone deficiency in adults","volume":"344","author":"Hoffman","year":"1994","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.nec.2019.05.009_bib53","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1365-2265.1997.1851001.x","article-title":"Insulin-like growth factor-I in growth hormone-deficient adults: relationship to population-based normal values, body composition and insulin tolerance test","volume":"46","author":"Svensson","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.nec.2019.05.009_bib54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2265.1994.tb03793.x","article-title":"An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year","volume":"41","author":"Jones","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.nec.2019.05.009_bib55","first-page":"1467","article-title":"Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues","volume":"85","author":"Hoeck","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.nec.2019.05.009_bib56","first-page":"617","article-title":"Glucagon-initiated human growth hormone release: a comparative study","volume":"107","author":"Cain","year":"1972","journal-title":"Can Med Assoc J"},{"issue":"3","key":"10.1016\/j.nec.2019.05.009_bib57","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/EJE-09-0824","article-title":"Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery","volume":"162","author":"Berg","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.nec.2019.05.009_bib58","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1210\/jc.2002-021094","article-title":"The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval","volume":"88","author":"Darzy","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.nec.2019.05.009_bib59","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1210\/jc.2005-0304","article-title":"The utility of the growth hormone (GH) releasing hormone-arginine test for diagnosing GH deficiency in adults with childhood acute lymphoblastic leukemia treated with cranial irradiation","volume":"90","author":"Bjork","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.nec.2019.05.009_bib60","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1210\/jc.2007-2734","article-title":"Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement","volume":"93","author":"Biller","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.nec.2019.05.009_bib61","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1046\/j.1365-2265.1996.00855.x","article-title":"The assessment of growth hormone status in normal young adult males using a variety of provocative agents","volume":"45","author":"Rahim","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.nec.2019.05.009_bib62","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1210\/jc.2013-1157","article-title":"Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency","volume":"98","author":"Garcia","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.nec.2019.05.009_bib63","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1210\/jc.2018-00665","article-title":"Macimorelin as a diagnostic test for adult GH deficiency","volume":"103","author":"Garcia","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"10.1016\/j.nec.2019.05.009_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.15.S2.1","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients---2009 update","volume":"15","author":"Cook","year":"2009","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.nec.2019.05.009_bib65","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2265.2004.02021.x","article-title":"Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study","volume":"60","author":"Biermasz","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.nec.2019.05.009_bib66","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1210\/jc.2002-020542","article-title":"Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle","volume":"88","author":"Bramnert","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.nec.2019.05.009_bib67","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-2265.1999.00695.x","article-title":"GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety","volume":"50","author":"Abs","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"10.1016\/j.nec.2019.05.009_bib68","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1210\/jc.2003-030461","article-title":"Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume","volume":"88","author":"Barker","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.nec.2019.05.009_bib69","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/neuros\/nyx020","article-title":"Long-term endocrine outcomes following endoscopic endonasal transsphenoidal surgery for acromegaly and associated prognostic factors.","volume":"81","author":"Babu","year":"2017","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.nec.2019.05.009_bib70","first-page":"719","article-title":"Assessment of long-term remission of acromegaly following surgery","volume":"98","author":"Krieger","year":"2003","journal-title":"J\u00a0Neurosurg"},{"issue":"2","key":"10.1016\/j.nec.2019.05.009_bib71","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4103\/0028-3886.177622","article-title":"Can immediate postoperative random growth hormone levels predict long-term cure in patients with acromegaly?","volume":"64","author":"Dutta","year":"2016","journal-title":"Neurol India"},{"issue":"4","key":"10.1016\/j.nec.2019.05.009_bib72","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrendo.2014.21","article-title":"Expert consensus document: a consensus on the medical treatment of acromegaly","volume":"10","author":"Giustina","year":"2014","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.nec.2019.05.009_bib73","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2265.2009.03620.x","article-title":"A\u00a0randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegaly","volume":"71","author":"Trainer","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.nec.2019.05.009_bib74","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1210\/jc.2011-0654","article-title":"Cotreatment with pegvisomant and a somatostatin analog (SA) in SA-responsive acromegalic patients","volume":"96","author":"Madsen","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.nec.2019.05.009_bib75","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1210\/jc.2010-2443","article-title":"Place of cabergoline in acromegaly: a meta-analysis","volume":"96","author":"Sandret","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.nec.2019.05.009_bib76","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00006123-199902000-00006","article-title":"Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results","volume":"44","author":"Tyrrell","year":"1999","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.nec.2019.05.009_bib77","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1056\/NEJM198308043090505","article-title":"Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma","volume":"309","author":"Serri","year":"1983","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.nec.2019.05.009_bib78","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4158\/EP161446.OR","article-title":"Surgical outcomes of prolactinomas in recent era: results of a heterogenous group","volume":"23","author":"Donegan","year":"2017","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.nec.2019.05.009_bib79","first-page":"307","article-title":"Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery","volume":"97","author":"Amar","year":"2002","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.nec.2019.05.009_bib80","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.wneu.2016.09.066","article-title":"Time course of resolution of hyperprolactinemia after transsphenoidal surgery among patients presenting with pituitary stalk compression","volume":"97","author":"Zaidi","year":"2017","journal-title":"World Neurosurg"},{"issue":"2","key":"10.1016\/j.nec.2019.05.009_bib81","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/21548331.1980.11946556","article-title":"Prolactin: physiology and pathology","volume":"15","author":"Tolis","year":"1980","journal-title":"Hosp Pract"},{"issue":"5","key":"10.1016\/j.nec.2019.05.009_bib82","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2265.1991.tb00312.x","article-title":"Megavoltage pituitary irradiation in the management of prolactinomas: long-term follow-up","volume":"34","author":"Tsagarakis","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.nec.2019.05.009_bib83","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11102-007-0014-1","article-title":"Temozolomide in the treatment of an invasive prolactinoma resistant to dopamine agonists","volume":"10","author":"Neff","year":"2007","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.nec.2019.05.009_bib84","first-page":"621","article-title":"Long-term response of pituitary carcinoma to temozolomide. Report of two cases","volume":"105","author":"Fadul","year":"2006","journal-title":"J\u00a0Neurosurg"}],"container-title":["Neurosurgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368019300452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368019300452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:01:51Z","timestamp":1760904111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042368019300452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":84,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1042368019300452"],"URL":"https:\/\/doi.org\/10.1016\/j.nec.2019.05.009","relation":{},"ISSN":["1042-3680"],"issn-type":[{"value":"1042-3680","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine Outcomes After Pituitary Surgery","name":"articletitle","label":"Article Title"},{"value":"Neurosurgery Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nec.2019.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}